1.
Marlene Troch, Constanze Jonak, Leonhard Müllauer, Andreas Püspök, Michael Formanek, Wolfgang Hauff, Christoph C. Zielinski, Andreas Chott, Markus Raderer. A phase II study of bortezomib in patients with MALT lymphoma. Haematologica 2009;94(5):738-742; https://doi.org/10.3324/haematol.2008.001537.